Abstract
Objective
Myroides species are mostly low-grade opportunistic pathogens and infect immunocompromised patients. Reports of Myroides spp. increased from clinical samples due to unique developments in molecular microbiology. However, clinical importance of this microorganism in intensive care units’ patients is debated. We aimed to determine whether Myroides spp. strains isolated from urinary catheter cultures of patients in intensive care units are led to an infection or colonization by examining the risk factors of the patients between January 2018 and December 2022.
Materials and Methods
In a university hospital, the patients who Myroides spp.isolated from urine cultures in intensive care units between January 2018 and December 2022 were included in the study. The method and reasons of taking urine samples, the presence of a urinary catheter, blood cultures samples in terms of urinary sepsis, the antimicrobial susceptibility of the isolates, and hospital stay were evaluated retrospectively. Also, control culture samples were taken after 24 and 72 hours by changing the urinary catheters of these patients.
Results: Thirty-six patients were enrolled to the study. Urine cultures were taken for investigate the source of infection in 23 patients, and nine for control urinary culture and in three patients for macroscopic urine blurred and in one patient to detect colonization before urinary surgery. There was not any blood culture positivity found. All Myroides spp. isolated patients had urinary catheter. Average length of hospital stay was determined as 41.3 days (7-355). A total 34 of the 36 isolated Myroides spp. were pan-drug resistant. Antibacterial treatment was not initiated in any of the patients. Urinary catheters change after first isolation of Myroides spp. was recommended in all patients. After the patients’ urinary catheters were changed, Myroides spp. were not grown in the control culture samples taken 24 and 72 hours after.
Conclusion
As a result of our study, Myroides spp. were isolated especially in patients with long hospital stays and urinary catheters. It was determined that the patients were controlled without treatment, only with urinary catheter replacement. We believe that this agent should be evaluated as having a very high rate of urinary colonization, and the urinary catheter should be changed first, urinary symptoms should be followed up, and unnecessary antimicrobial use should be avoided.
Keywords: Myroides species, urinary tract infections, colonization
References
- Schröttner P, Rudolph WW, Eing BR, Bertram S, Gunzer F. Comparison of VITEK2, MALDI-TOF MS, and 16S rDNA sequencing for identification of Myroides odoratus and Myroides odoratimimus. Diagn Microbiol Infect Dis. 2014;79:155-9.
- Zumla A. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Lancet Infect Dis. 2010;10:303-4.
- Vancanneyt M, Segers P, Torck U, Hoste B, Bernardet JF, Vandamme P, et al. Reclassification of Flavobacterium odoratum (Stutzer 1929) strains to a new genus, Myroides, as Myroides odoratus comb. Nov. and Myroides odoratimimus sp. nov. Int J Syst Bacteriol. 1996;46:926-32.
- Benedetti P, Rassu M, Pavan G, Sefton A, Pellizzer G. Septic shock, pneumonia, and soft tissue infection due to Myroides odoratimimus: report of a case and review of Myroides infections. Infection. 2011;39:161-5.
- Elantamilan D, Lyngdoh VW, Choudhury B, Khyriem AB, Rajbongshi J. Septicaemia caused by Myroides spp. - A case report. JMM Case Reports. 2015;5:1-4.
- Hu SH, Yuan SX, Qu H, Jiang T, Zhou YJ, Wang MX, et al. Antibiotic resistance mechanisms of Myroides sp. J Zhejiang Univ Sci B. 2016;17:188-99.
- EUCAST (2021). Available from: URL:https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_14.0_Breakpoint_Tables.pdf.
- Willems P, Muller J, Verhaegen J, Saegeman V, Desmet S. How to treat a fulminant erysipelas and sepsis caused by Myroides odoratimimus: case report and literature review. Acta Clin Belg. 2017;72:331-5.
- Holmes B, Snell JJ, Lapage SP. Flavobacterium odoratum: a species resistant to a wide range of antimicrobial agents. J Clin Pathol. 1979;32:73-7.
- Ktari S, Mnif B, Koubaa M, Mahjoubi F, Ben Jemaa M, Mhiri MN, Hammami A. Nosocomial outbreak of Myroides odoratimimus urinary tract infection in a Tunisian hospital. J Hosp Infect. 2012;80:77-81.
- Licker M, Sorescu T, Rus M, Cirlea N, Horhat F, Jurescu C, et al. Extensively drug-resistant Myroides odoratimimus - a case series of urinary tract infections in immunocompromised patients. Infect Drug Resist. 2018;11:743-9.
- Yağci A, Cerikcioğlu N, Kaufmann M E, Malnick H, Söyletir G, Babacan F, et al. Molecular typing of Myroides odoratimimus (Flavobacterium odoratum) urinary tract infections in a Turkish hospital. Eur J Clin Microbiol Infect Dis. 2000;19:731-2.
- Kutlu HH, Avcı M, Dal T, Arı O, Durmaz R. A Healthcare-Associated Outbreak of Urinary Tract Infections Due to Myroides odoratimimus. Jpn J Infect Dis. 2020;73:421-6.
- Kara I, Kalem F, Unaldı O, Arslan U. Myroides Sp, a Rare Opportunistic Infective Agent, at a Hospital in Turkey. Southeast Asian Journal of Tropical Medicine and Public Health. 2019;50:248-57.
- Crum-Cianflone NF, Matson RW, Ballon-Landa G. Fatal case of necrotizing fasciitis due to Myroides odoratus. Infection. 2014;42:931-5.
- Prateek S, Gupta P, Mittal G, Singh AK. Fatal Case of Pericardial Effusion Due to Myroides Odoratus: A Rare Case Report. J Clin Diagn Res. 2015;9:DD01-2.
Copyright and license
Copyright © 2024 The Author(s). This is an open access article distributed under the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.
